Analyst: Expect prasugrel OK by May
Analyst: Expect prasugrel OK by May Eli Lilly and Co. should win regulatory approval for its blood-thinner prasugrel by the end of the month, according to one Wall Street analyst. Dr. Tim Anderson, an analyst at Sanford C. Bernstein & Co., made the prediction in a note to investors April 21. He added that Wall […]